Why the study?
Does an inactivated enterovirus 71 vaccine demonstrate acceptable tolerability and immunogenicity in healthy adults and children?
Population
100 healthy participants, stratified by age, in Donghai County, Jiangsu Province, China.
Design
Other, open-label
Follow-up
28 days after each shot
Authors
Loading...
Supports advancing inactivated EV71 vaccine to Phase 2 trials; leaves open long-term efficacy and protection in at-risk children.
Does an inactivated enterovirus 71 vaccine demonstrate acceptable tolerability and immunogenicity in healthy adults and children?
The inactivated EV71 vaccine demonstrated acceptable tolerability and elicited a good immune response in healthy Chinese adults and children in a phase 1 trial.
Meng et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: